Literature DB >> 3393398

Impairment of hemodynamics with increasing mean airway pressure during high-frequency oscillatory ventilation.

J H Traverse1, H Korvenranta, E M Adams, D A Goldthwait, W A Carlo.   

Abstract

We investigated the effects of changes in mean airway pressure (Paw), oscillatory frequency and lung compliance on cardiac output (CO) and pulmonary vascular resistance in seven adult cats (3.0 +/- 0.6 kg) during high-frequency oscillatory ventilation (HFOV). The cats were anesthetized with chloralose and urethane and ventilated with a high-frequency oscillator at Paw of 4, 8, 12, and 16 cm H2O and frequencies of 3, 6, 12, 16, and 20 Hz. Saline lavage was used to reduce lung compliance. CO was continuously recorded with an electromagnetic flow probe placed around the aorta and pulmonary vascular resistance was calculated from left atrial and pulmonary artery pressures. Lung lavage reduced static compliance of the respiratory system but did not change CO during pressure-limited ventilation. During HFOV, CO was higher in animals after lung lavage at each Paw. As Paw was raised from 4 to 16 cm H2O during HFOV, CO decreased from 133 +/- 36 to 87 +/- 31 ml/min kg in animals with normal lungs and decreased from 153 +/- 33 to 107 +/- 19 ml/min kg after lung lavage (both p less than 0.001). Increasing Paw was also associated with an increase in pulmonary vascular resistance both before and after lung lavage (both p less than 0.005). Changes in frequency did not significantly alter CO or pulmonary vascular resistance. We conclude that the interaction between the heart and lungs during HFOV is largely mediated by Paw and compliance of the respiratory system. Furthermore, regardless of the degree of lung compliance, cardiac function may be impaired during HFOV as Paw is elevated.

Entities:  

Mesh:

Year:  1988        PMID: 3393398     DOI: 10.1203/00006450-198806000-00020

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  7 in total

1.  Effects of high-frequency oscillatory ventilation on oleic acid-induced lung injury in sheep.

Authors:  Rikimaru Nakagawa; Tomonobu Koizumi; Koichi Ono; Sumiko Yoshikawa; Kenji Tsushima; Tetsutarou Otagiri
Journal:  Lung       Date:  2008-06-26       Impact factor: 2.584

2.  Effects of high-frequency oscillatory ventilation on systemic and cerebral hemodynamics and tissue oxygenation: an experimental study in pigs.

Authors:  Jan Florian Heuer; Philip Sauter; Jürgen Barwing; Peter Herrmann; Thomas A Crozier; Annalen Bleckmann; Tim Beißbarth; Onnen Moerer; Michael Quintel
Journal:  Neurocrit Care       Date:  2012-10       Impact factor: 3.210

Review 3.  High-frequency ventilation in preterm infants and neonates.

Authors:  Benjamin W Ackermann; Daniel Klotz; Roland Hentschel; Ulrich H Thome; Anton H van Kaam
Journal:  Pediatr Res       Date:  2022-02-08       Impact factor: 3.756

4.  Cardiovascular responses to high-frequency oscillatory ventilation during acute lung injury in sheep.

Authors:  Rikimaru Nakagawa; Tomonobu Koizumi; Koichi Ono; Kenji Tsushima; Sumiko Yoshikawa; Keishi Kubo; Tetutarou Otagiri
Journal:  J Anesth       Date:  2007-08-01       Impact factor: 2.078

5.  Hemodynamic effects of high-frequency oscillatory ventilation in severe pediatric respiratory failure.

Authors:  J A Gutiérrez; D L Levin; L O Toro-Figueroa
Journal:  Intensive Care Med       Date:  1995-06       Impact factor: 17.440

6.  Comparisons of different mean airway pressure settings during high-frequency oscillation in inflammatory response to oleic acid-induced lung injury in rabbits.

Authors:  Koichi Ono; Tomonobu Koizumi; Rikimaru Nakagawa; Sumiko Yoshikawa; Tetsutarou Otagiri
Journal:  J Inflamm Res       Date:  2009-03-16

7.  Effect of a lung recruitment maneuver by high-frequency oscillatory ventilation in experimental acute lung injury on organ blood flow in pigs.

Authors:  Matthias David; Hendrik W Gervais; Jens Karmrodt; Arno L Depta; Oliver Kempski; Klaus Markstaller
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.